Showing 2,403 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Adherence

SA's new HIV challenge: patients who believe they've been healed

Editor's pick
Citizen
13 June 2017
PrEP science

Long-acting Injectable Antiretrovirals for PrEP: Will the tail wag the drug?

Editor's pick
AVAC
9 June 2017
Global health targets

Study: 1 in 3 Patients Starts HIV Treatment Late in 10 Countries

Editor's pick
Voice of America
9 June 2017
Treatment for women

Meds May Impact Prenatal Screening in HIV+ Patients

Editor's pick
MedPage Today HIV/AIDS
8 June 2017
Resistance

Experts raise concerns over high HIV treatment failure in Kenya

Editor's pick
The Standard
6 June 2017
New & experimental HIV treatments

ViiV Healthcare Files Regulatory Submissions for First Two-Drug HIV Maintenance Regimen

Editor's pick
ViiV
2 June 2017
Changing treatment

HIV: A therapeutic advance for resource-limited settings

Editor's pick
Eurekalert Inf Dis
31 May 2017
Pharmaceutical industry

Gilead and GSK go head-to-head with similar HIV drug data

Editor's pick
Reuters
31 May 2017
New & experimental HIV treatments

Gilead’s Investigational Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for the Treatment of HIV-1 Meets Primary Endpoint in Four Phase 3 Studies

Editor's pick
Gilead press release
30 May 2017
Contraception

Taking Birth Control With HIV Treatment or PrEP Is Largely OK

Editor's pick
Poz
30 May 2017
HIV treatment

The Truth About HIV

Editor's pick
BBC iPlayer (UK only, available until 24 June)
26 May 2017
Money

Life insurance policyholders with HIV urged to review life cover term

Editor's pick
Professional Adviser
24 May 2017
Generic medicines

Unexpected side effects with generic abacavir – and potential for rare reactions to other generic ARVs

Editor's pick
HIV i-Base
23 May 2017
New & experimental HIV treatments

Merck Receives CHMP Positive Opinion Recommending Approval of ISENTRESS® (raltegravir) 600 mg in the European Union

Editor's pick
Merck press release
22 May 2017
Pharmaceutical industry

CHMP recommends for approval generic version of Atripla

Editor's pick
EATG
22 May 2017
The search for an HIV prevention vaccine

Stock market models accurately predict changes in HIV over time

Editor's pick
Healio
18 May 2017
History of HIV & AIDS

The HIV story is not over - the spectre of anti-science threatens our advances

Editor's pick
The Guardian
17 May 2017
Pharmaceutical industry

Gilead's last chronic HIV drug — and what it plans to do now

Editor's pick
San Francisco Business Times
11 May 2017
Treatment outcomes & life expectancy

HIV life expectancy 'near normal' thanks to new drugs

Editor's pick
BBC Health
11 May 2017
Ageing & HIV

New Study Reveals why people with HIV are more likely to develop Emphysema

Editor's pick
Weill Cornell Medicine
10 May 2017
Undetectable viral load & treatment as prevention

Gay New Zealand welcomes removal of HIV meds restriction

Editor's pick
Gay New Zealand
8 May 2017
PrEP

BHIVA response to The Irish Times article 'Anti-HIV drug removes personal responsibility'

Editor's pick
BHIVA
24 April 2017
Pregnancy and vertical transmission

The living legacy of the Global Plan: eliminating HIV in children

Editor's pick
UNAIDS
20 April 2017
New & experimental HIV treatments

Orphan Drug Designation for CytoDyn's PRO 140 Declined by the FDA

Editor's pick
Cytodyn press release
18 April 2017